KR20230099528A - Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition - Google Patents

Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition Download PDF

Info

Publication number
KR20230099528A
KR20230099528A KR1020210188966A KR20210188966A KR20230099528A KR 20230099528 A KR20230099528 A KR 20230099528A KR 1020210188966 A KR1020210188966 A KR 1020210188966A KR 20210188966 A KR20210188966 A KR 20210188966A KR 20230099528 A KR20230099528 A KR 20230099528A
Authority
KR
South Korea
Prior art keywords
larvae
composition
extract
white
immune function
Prior art date
Application number
KR1020210188966A
Other languages
Korean (ko)
Inventor
유상미
강창희
김민진
김기영
Original Assignee
국립낙동강생물자원관
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 국립낙동강생물자원관 filed Critical 국립낙동강생물자원관
Priority to KR1020210188966A priority Critical patent/KR20230099528A/en
Publication of KR20230099528A publication Critical patent/KR20230099528A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/63Arthropods
    • A61K35/64Insects, e.g. bees, wasps or fleas
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00Function of food ingredients
    • A23V2200/30Foods, ingredients or supplements having a functional effect on health
    • A23V2200/324Foods, ingredients or supplements having a functional effect on health having an effect on the immune system
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2250/00Food ingredients
    • A23V2250/20Natural extracts
    • A23V2250/204Animal extracts
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Insects & Arthropods (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Husbandry (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Nutrition Science (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The present invention relates to a composition for enhancing immune functions containing an extract of Protaetia brevitarsis larvae as an active component. According to the present invention, provided are the composition for enhancing immune functions that can improve immune function by promoting the production of NO, PGE2, IL-6, and IL-12 in macrophages using Protaetia brevitarsis larvae, and a method for manufacturing the composition for enhancing immune functions using the extract of Protaetia brevitarsis larvae.

Description

흰점박이꽃무지 유충 추출물을 함유하는 면역기능 강화용 조성물 및 면역기능 강화용 조성물을 제조하는 방법{Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition}Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition}

본 발명은 흰점박이꽃무지 유충 추출물을 함유하는 면역기능 강화용 조성물 및 면역기능 강화용 조성물을 제조하는 방법에 관한 것으로, 보다 상세하게는 굼벵이라고도 불리는 흰점박이꽃무지 유충의 추출물은 생쥐의 대식세포의 활성 및 NO생성을 촉진하는 동시에 PGE2, IL-6, IL-12의 생성을 촉진하며, TLR-4를 통한 면역의 증진에 우수한 효과를 나타냄으로써, 면역 활성화 및 증강 효과가 있는 면역기능 강화용 조성물 및 그 조성물을 제조하는 방법에 관한 것이다.The present invention relates to a composition for strengthening immune function containing an extract of larvae of white-spotted radishes and a method for preparing the composition for enhancing immune function, and more particularly, the extract of larvae of white-spotted radishes, also called slugs, is used to treat macrophages of mice It promotes the activation and NO production and at the same time promotes the production of PGE2, IL-6, IL-12, and exhibits excellent effects in enhancing immunity through TLR-4, thereby enhancing immune function with immune activation and enhancing effects. It relates to compositions and methods of making the compositions.

인간의 면역체계 중 선천면역계는 병원균에 대한 식작용이 주요 기능이며 대식세포, 단구세포, 중성구 등이 이에 포함된다. 이들은 병원균 침입에 대하여 기억 기능을 갖고 있으며, 면역 시스템이 있어 매우 중요한 역할을 수행한다. 특히 대식세포는 가장 중요한 선천 면역계 세포로서 면역 반응에 있어 필수적인 역할을 한다. 감염원에 대한 식작용을 통하여 nitric oxide(NO), prostagladin E2(PGE2)와 같은 면역 매개 물질을 생산하며, 염증 반응 작용 물질인 interleukin(IL)-6, IL-12와 같은 싸이토카인들을 생산하기도 한다. 이러한 반응들은 주로 nuclear factor-κB(NF-κB)에 의해 조절받는 것으로 알려져 있으며, NF-κB에 의해 다양한 면역 매개 물질과 염증 반응 물질들의 합성이 활성화된다. NO의 경우 inducible NO synthase(iNOS)에 의해 합성되고, PGE2의 경우 cyclooxygenase-2(COX-2)에 의해 합성이 유도되며 이들은 NF-κB에 의해 조절받고 있다. 따라서 면역 반응에 있어 NF-κB는 매우 중요한 전사인자라 할 수 있다. Among the human immune systems, the innate immune system has a major function of phagocytosis against pathogens, and includes macrophages, monocytes, and neutrophils. They have a memory function against invading pathogens and play a very important role in the immune system. In particular, macrophages are the most important cells of the innate immune system and play an essential role in the immune response. Through phagocytosis on infectious agents, it produces immune mediators such as nitric oxide (NO) and prostagladin E 2 (PGE 2 ), and also produces cytokines such as interleukin (IL)-6 and IL-12, which are inflammatory response substances. . These reactions are known to be mainly regulated by nuclear factor-κB (NF-κB), and the synthesis of various immune mediators and inflammatory response substances is activated by NF-κB. NO is synthesized by inducible NO synthase (iNOS), and PGE 2 is synthesized by cyclooxygenase-2 (COX-2), which is regulated by NF-κB. Therefore, NF-κB is a very important transcription factor in the immune response.

곤충 단백질은 세계적 식량난 해소를 위한 대체 식품자원으로서 주목받고 있다. 현재 세계 곤충 산업은 38조원 규모이며 유럽에서는 곤충 10종을 식용으로 허가, 햄버거 패티 개발 등 식용 곤충 시장을 선점하여 경제적 효과를 얻고 있다. 국내에서는 농림축산식품부에서 ‘축산법 시행규칙 위임 고시’를 통하여 곤충 14종을 축으로 등록하여 관리하고 있으며, 곤충산업 육성 종합계획을 발표하는 등 지속적인 곤충산업에 관심을 기울이고 있다. Insect protein is attracting attention as an alternative food resource to solve the global food crisis. Currently, the global insect industry is worth 38 trillion won, and in Europe, 10 types of insects are licensed for food, and they are gaining economic effects by preoccupying the edible insect market, such as developing hamburger patties. In Korea, the Ministry of Agriculture, Food and Rural Affairs registers and manages 14 species of insects as axes through the ‘Announcement on Enforcement Regulations of the Livestock Act’, and pays attention to the insect industry continuously by announcing a comprehensive plan to foster the insect industry.

흰점박이꽃무지 유충인 굼벵이는 예전부터 간에서 비롯되는 질병(간암, 간경화, 간염, 피로해소)에 특효 약재로서 사용되어 왔다. 그 외에도 유방암, 월경불통, 시력감퇴, 백내장, 파상풍, 각종 성인병을 치료하는데 효과가 있다는 기록이 남아 있다. 하지만 현재까지 굼벵이의 약리적 효능 및 기전에 대한 연구는 매우 미비한 실정이다. 최근의 연구 결과들을 보면 굼벵이는 58%의 조단백질, 17%의 조지방, 11%의 탄수화물과 그 외 섬유질을 함유하는 것으로 보고되어 있으며, 식품소재로 개발하기 위한 다양한 연구들이 진행되고 있다. 특히 간보호 기능과 항암 효능에 대한 연구가 주를 이루고 있는 상황이다. 하지만 현재까지 굼벵이가 갖는 면역기능 개선에 대한 연구는 전무하며 뚜렷한 면역기능 강화 기전에 대한 보고 역시 전무한 상황이다. Slugs, the larvae of the white-spotted flower, have been used as a special medicine for diseases originating from the liver (liver cancer, liver cirrhosis, hepatitis, and fatigue). In addition, there are records that it is effective in treating breast cancer, dysmenorrhea, loss of vision, cataract, tetanus, and various adult diseases. However, studies on the pharmacological efficacy and mechanism of slugs have been very insufficient to date. Recent studies have reported that slugs contain 58% of crude protein, 17% of crude fat, 11% of carbohydrates and other fibers, and various studies are being conducted to develop them as food materials. In particular, research on hepatoprotective function and anticancer efficacy is the main focus. However, there is no study on the improvement of the immune function of slugs so far, and there is no report on a clear immune function enhancement mechanism.

한국특허등록공보 제0377252호Korean Patent Registration No. 0377252

본 발명은 상기와 같은 문제점을 해결하기 위하여 안출된 것으로, 예전부터 다양한 질병에 대한 약재로 이용되어 온 흰점박이꽃무지 유충을 이용하여 대식세포의 NO와 PGE2, IL-6, IL-12의 생성을 촉진함으로써 면역기능을 증진시킬 수 있는 면역기능 강화용 조성물을 제공하는 것을 그 목적으로 한다.The present invention was made to solve the above problems, and production of NO, PGE2, IL-6, and IL-12 in macrophages using white-spotted flower radish larvae, which have been used as medicines for various diseases from the past. Its object is to provide a composition for enhancing immune function that can enhance immune function by promoting.

본 발명의 다른 목적은 흰점박이꽃무지 유충의 추출물을 이용하여 면역기능 강화용 조성물을 제조하는 방법을 제공하는 것이다.Another object of the present invention is to provide a method for preparing a composition for enhancing immune function using an extract of the larvae of the white-spotted flower radish.

본 발명은 상기의 목적을 달성하기 위한 것으로, 흰점박이꽃무지 유충 추출물을 유효성분으로 포함하는 면역기능 강화용 조성물을 제공한다.The present invention has been made to achieve the above object, and provides a composition for enhancing immune function comprising an extract from the larvae of white-spotted radishes as an active ingredient.

또한, 상기 흰점박이꽃무지 유충 추출물은 열수 추출물인 것을 특징으로 한다.In addition, the white-spotted flower radish larvae extract is characterized in that the hot water extract.

또한, 상기 열수 추출물은 흰점박이꽃무지 유충을 건조 후 분쇄한 것을 증류수를 이용하여 추출한 후, 동결 건조하여 수득한 것을 특징으로 한다.In addition, the hot water extract is characterized in that it is obtained by drying and pulverizing white-spotted flower larvae, extracting them using distilled water, and then freeze-drying them.

또한, 상기 흰점박이꽃무지 유충 추출물은, 대식세포의 활성을 촉진하고 NO 생성을 촉진하는 동시에, PGE2, IL-6, IL-12의 생성을 촉진하는 효과를 갖는 것을 특징으로 한다.In addition, the white-spotted radish larvae extract is characterized in that it has an effect of promoting the activity of macrophages and NO production, and at the same time promoting the production of PGE2, IL-6, and IL-12.

본 발명은 상기의 목적을 달성하기 위한 것으로, (a) 흰점박이꽃무지 유충을 건조하는 단계; (b) 상기 건조된 흰점박이꽃무지 유충을 분쇄하는 단계; (c) 상기 분쇄된 흰점박이꽃무지 유충을 증류수에 침지하는 단계; (d) 상기 용액을 진공 필터를 이용하여 용매를 제거하는 단계; 및 (e) 상기 (d) 용액을 동결 건조하여 흰점박이꽃무지 유충 추출물을 수득하는 단계를 포함하는 면역기능 강화용 조성물을 제조하는 방법을 제공한다.The present invention is to achieve the above object, (a) drying the white-spotted flower iris larvae; (b) grinding the dried white-spotted flower larvae; (c) immersing the pulverized white-spotted flower larvae in distilled water; (d) removing the solvent from the solution using a vacuum filter; and (e) freeze-drying the solution (d) to obtain an extract of the white-spotted radishes larvae.

본 발명에 의하면, 흰점박이꽃무지 유충을 이용하여 대식세포의 NO와 PGE2, IL-6, IL-12의 생성을 촉진함으로써 면역기능을 증진시킬 수 있는 면역기능 강화용 조성물 및 흰점박이꽃무지 유충의 추출물을 이용하여 면역기능 강화용 조성물을 제조하는 방법을 제공할 수 있다.According to the present invention, a composition for enhancing immune function capable of enhancing immune function by promoting the production of NO, PGE2, IL-6, and IL-12 in macrophages using white-spotted flower larvae and white-spotted flower larvae It is possible to provide a method for preparing a composition for enhancing immune function using an extract of.

도 1은 본 발명의 일실시예에 따른 조성물을 이용한 세포 모양 및 생존률 실험의 결과를 나타낸 이미지 사진 및 그래프.
도 2는 본 발명의 일실시예에 따른 조성물을 이용한 NO 및 PGE2 생성 실험의 결과를 나타낸 이미지 사진 및 그래프.
도 3은 본 발명의 일실시예에 따른 조성물을 이용한 IL-6 및 IL-12 생성 실험의 결과를 나타낸 이미지 사진 및 그래프.
도 4는 본 발명의 일실시예에 따른 조성물을 이용한 NF-κB 활성 실험의 결과를 나타낸 이미지 사진.
도 5는 본 발명의 일실시예에 따른 조성물을 이용한 면역기능 강화 기전 실험의 결과를 나타낸 이미지 사진.
1 is a photographic image and a graph showing the results of cell shape and viability experiments using a composition according to an embodiment of the present invention.
Figure 2 is an image photograph and graph showing the results of NO and PGE 2 production experiments using a composition according to an embodiment of the present invention.
Figure 3 is a photographic image and graph showing the results of IL-6 and IL-12 production experiments using the composition according to an embodiment of the present invention.
Figure 4 is a photographic image showing the results of an NF-κB activity experiment using a composition according to an embodiment of the present invention.
Figure 5 is a photographic image showing the results of the immune function enhancement mechanism test using a composition according to an embodiment of the present invention.

본 발명은 흰점박이꽃무지 유충 추출물을 유효성분으로 포함하는 면역기능 강화용 조성물에 관한 것이다.The present invention relates to a composition for enhancing immune function comprising an extract from the larvae of white-spotted radishes as an active ingredient.

이하, 본 발명을 첨부한 도면을 참조하여 상세하게 설명한다.Hereinafter, the present invention will be described in detail with reference to the accompanying drawings.

본 발명은 흰점박이꽃무지 유충인 굼벵이가 가지는 면역기능 강화에 대해 확인하고 그 기전을 규명한 것으로, 굼벵이 추출물은 NO와 PGE2, IL-6, IL-12의 생성을 증가시켰고, 이는 TLR4 수용체 자극을 통한 하위 신호전달 경로를 통한 효과임을 확인하였다. 면역 반응 중, 초기 감염에 있어 대식세포는 매우 중요한 역할을 수행한다. 감염원에 대한 식작용을 통하여 감염원에 대항하는 면역 인자들을 생성하고 방출하게 된다. 이렇게 방출된 인자들은 선천 면역계의 활성화를 유도하고 대식세포는 항원 발현을 통하여 특이적인 감염원 인지 기능을 부여하게 된다. MHCII 및 CD80, CD86 분자들을 통하여 감염원의 특정 분자 패턴을 인지시키고 TLR과 같은 수용체 자극을 통한 면역 반응을 유도한다. 본 발명은 굼벵이 추출물이 대식세포를 자극시키고 TLR4의 자극을 유도함으로서 강한 면역 반응을 유도한 것을 확인할 수 있었다. The present invention confirms the enhancement of immune function of slugs, which are white -spotted flower larvae, and identifies the mechanism. It was confirmed that the effect was through the lower signaling pathway through stimulation. During the immune response, macrophages play a very important role in initial infection. Through phagocytosis on the infectious agent, immune factors against the infectious agent are produced and released. The released factors induce activation of the innate immune system, and macrophages endow specific infectious agent recognition functions through antigen expression. Through MHCII, CD80, and CD86 molecules, specific molecular patterns of infectious agents are recognized and an immune response is induced through receptor stimulation such as TLR. The present invention confirmed that the slug extract induced a strong immune response by stimulating macrophages and inducing stimulation of TLR4.

본 발명의 일양태에 따른 흰점박이꽃무지 유충 추출물은 열수 추출물인 것을 특징으로 한다. 흰점박이꽃무지 유충을 건조한 후 분쇄하였고, 이를 증류수에 침지한 후 용매를 제거하여 사용할 수 있다.The white-spotted flower radish larvae extract according to one embodiment of the present invention is characterized in that it is a hot water extract. The white-spotted flower larvae were dried and then pulverized, and can be used by immersing them in distilled water and removing the solvent.

본 발명에 따른 흰점박이꽃무지 유충 추출물은, 대식세포의 활성을 촉진하고 NO 생성을 촉진하는 동시에, PGE2, IL-6, IL-12의 생성을 촉진하는 효과를 갖는 것을 특징으로 한다.The white-spotted radish larvae extract according to the present invention is characterized in that it promotes macrophage activity and NO production, and at the same time promotes the production of PGE2, IL-6, and IL-12.

본 발명의 일양태에 따른 면역기능 강화용 조성물을 제조하는 방법은 다음과 같은 단계를 포함하여 구성된다:The method for preparing a composition for enhancing immune function according to one aspect of the present invention is composed of the following steps:

(a) 흰점박이꽃무지 유충을 건조하는 단계(a) drying the white-spotted flower larvae

(b) 상기 건조된 흰점박이꽃무지 유충을 분쇄하는 단계(b) grinding the dried white-spotted flower larvae

(c) 상기 분쇄된 흰점박이꽃무지 유충을 증류수에 침지하는 단계(c) immersing the pulverized white-spotted flower larvae in distilled water

(d) 상기 용액을 진공 필터를 이용하여 용매를 제거하는 단계(d) removing the solvent from the solution using a vacuum filter

(e) 상기 (d) 용액을 동결 건조하여 흰점박이꽃무지 유충 추출물을 수득하는 단계(e) freeze-drying the solution (d) to obtain an extract of the white-spotted flower radish larvae

이하, 실시예를 통하여 본 발명을 더욱 상세히 설명하고자 한다. 다만, 이들의 실시예는 오로지 본 발명을 예시하기 위한 것으로서, 본 발명의 범위가 이들 실시예에 의해 한정되는 것으로 해석되지 않는다 할 것이며, 본 기술분야에 통상의 지식을 가진 자는 본 발명의 기술적 사상을 벗어나지 않는 범위에서 실시예의 일부를 치환 및 변형하는 것이 가능함을 이해할 수 있을 것이다.Hereinafter, the present invention will be described in more detail through examples. However, these examples are only for illustrating the present invention, and the scope of the present invention will not be construed as being limited by these examples, and those skilled in the art will not be construed as limiting the technical spirit of the present invention. It will be understood that it is possible to substitute and modify parts of the embodiments within the range not departing from the above.

[실시예][Example]

굼벵이 열수추출물 제조Manufacturing slug hot water extract

굼벵이 시료는 희망곤충농장으로부터 공급받아 사용하였으며, 건조 후 분쇄하여 추출물 제조에 사용하였다. 시료 100g당 증류수 1L를 사용하여 1시간 동안 침지하였다. 용매를 vacuum 필터를 통하여 제거하였으며, -100℃에서 동결 건조하여 최종 추출물을 획득하였다. 추출 수율을 23%였다.The slug samples were supplied from the Hope Insect Farm and used, dried and then pulverized to prepare the extract. It was immersed for 1 hour using 1L of distilled water per 100g of sample. The solvent was removed through a vacuum filter, and freeze-dried at -100 ° C to obtain a final extract. The extraction yield was 23%.

[실험예][Experimental example]

가. 면역 세포 배양go. immune cell culture

생쥐의 대식세포인 RAW 264.7 세포주를 사용하여 실험을 진행하였으며, 세포 배양 조건은 DMEM 배지에 FBS 5%와 항생제 0.1%를 첨가하여 37℃, CO2 5% 환경에서 배양하였다.The experiment was conducted using RAW 264.7 cell line, which is a mouse macrophage, and the cell culture conditions were cultured in a 37°C, CO 2 5% environment by adding 5% FBS and 0.1% antibiotics to DMEM medium.

나. 세포 생존률 실험me. Cell viability experiment

세포 생존률 평가를 위해 MTT 시험법을 사용하였다. 면역세포를 1×105cell/mL 밀도로 배양하여 굼벵이 추출물을 0 ~ 800㎍/mL 농도로 처리하였다. LPS를 positive control로 사용하였고 500ng/mL 농도로 처리하였다. 굼벵이 추출물과 LPS 처리 24시간 후 MTT 시험을 실시하였으며, MTT 0.5mg/mL을 처리 30분 후 생성된 포마잔(formazan) 분자를 DMSO에 녹여냈다. 녹여낸 포마잔의 양은 엘리사 마이크로플래이트 리더기(ELISA microplate reader)를 사용하여 540nm에서 흡광도를 측정하였다. 세포 형태를 통한 관찰은 대물 현미경을 활용하여 수행하였다. The MTT assay was used to evaluate cell viability. The immune cells were cultured at a density of 1×10 5 cell/mL, and the slug extract was treated at a concentration of 0 to 800 μg/mL. LPS was used as a positive control and treated at a concentration of 500 ng/mL. MTT test was performed after 24 hours of treatment with slug extract and LPS, and formazan molecules generated after 30 minutes of treatment with 0.5 mg/mL of MTT were dissolved in DMSO. The amount of dissolved formazan was measured for absorbance at 540 nm using an ELISA microplate reader. Observation through cell morphology was performed using an objective microscope.

다. NO 생성 측정all. NO production measurement

Grisee 시험법을 사용하여 면역세포의 NO 생성량을 측정하였다. 실험은 면역세포를 1×105 cell/mL 밀도로 배양하여 굼벵이 추출물을 0 ~ 800㎍/mL, LPS를 500 ng/mL 농도로 처리 24시간 후에 진행하였다. 세포 배양액을 수집하고 같은 부피의 Griess 시약을 혼합한 15분 후에 마이크로플래이트 리더기(ELISA microplate reader)를 사용하여 590nm에서 흡광도를 측정하였다. NO 생산량은 NaNO2의 농도를 기준으로 산출하였다. The production of NO by immune cells was measured using the Grisee test method. The experiment was performed 24 hours after treatment by culturing immune cells at a density of 1×10 5 cell/mL and treating the slug extract at a concentration of 0 to 800 μg/mL and LPS at a concentration of 500 ng/mL. After 15 minutes of collecting the cell culture medium and mixing the same volume of Griess reagent, the absorbance was measured at 590 nm using an ELISA microplate reader. NO production was calculated based on the concentration of NaNO 2 .

라. PGEla. PGE 22 , IL-6, IL-12 생성 측정, IL-6, IL-12 production measurement

면역 매개체인 PGE2. IL-6, IL-12의 생성량 측정을 위하여 ELISA 시험법을 사용하였다. 실험은 면역세포를 1×105 cell/mL 밀도로 배양하여 굼벵이 추출물을 0 ~ 800㎍/mL, LPS를 500ng/mL 농도로 처리 48시간 후에 진행하였다. 세포 배양액을 수집하여 그 안에 함유되어 있는 PGE2. IL-6, IL-12의 농도를 마이크로플래이트 리더기(ELISA microplate reader)를 사용하여 450nm에서 흡광도를 측정하였다. The immune mediator PGE 2 . An ELISA test method was used to measure the amount of production of IL-6 and IL-12. The experiment was performed 48 hours after treatment by culturing immune cells at a density of 1×10 5 cell/mL and treating the slug extract at a concentration of 0 to 800 μg/mL and LPS at a concentration of 500 ng/mL. The cell culture fluid was collected and the PGE 2 contained therein. The concentrations of IL-6 and IL-12 were measured for absorbance at 450 nm using an ELISA microplate reader.

마. 단백질 발현 실험mind. Protein expression experiments

면역세포 내 함유되어 있는 총 단백질은 RIPA lysis buffer를 사용하여 추출하였다. RAW 264.7 세포를 lysis buffer에 넣고 4℃에서 30분간 용해시켰다. 그 후 14,000×g의 압력과 4℃ 환경에서 10분간 원심분리를 진행하여 단백질을 분리하였다. 핵 단백질과 세포질 단백질 분리 추출은 NE-PER nuclear and cytosolic extraction reagent를 사용하였다. 단백질 농도는 Bio-Rad protein assay kit를 사용하여 측정하였다. 그리고 단백질 발현 실험은 웨스턴 블롯(westerm blot) 시험법을 사용하였다. 단백질을 SDS-PAGE를 통하여 분리하고 폴리비닐레덴 디플루오라이드 멤브레인(polyvinylidene difluoride membrane)에 부착시켰다. 부착된 단백질은 탈지유(skim milk)를 사용하여 블록킹(blocking) 단계를 거친 후 1차 항체와 반응시킨다. 그 후 2차 항체와 다시 한 번 반응시킨 후 발광 정도를 확인한다.Total protein contained in immune cells was extracted using RIPA lysis buffer. RAW 264.7 cells were put in lysis buffer and lysed at 4°C for 30 minutes. Thereafter, the protein was separated by centrifugation for 10 minutes at a pressure of 14,000 × g and 4 ° C. For separation and extraction of nuclear and cytoplasmic proteins, NE-PER nuclear and cytosolic extraction reagent was used. Protein concentration was measured using the Bio-Rad protein assay kit. And protein expression experiments were performed using a western blot test method. Proteins were separated through SDS-PAGE and attached to a polyvinylidene difluoride membrane. The attached protein is reacted with a primary antibody after passing through a blocking step using skim milk. After that, after reacting with the secondary antibody once again, the degree of luminescence is confirmed.

바. mRNA 발현 실험bar. mRNA expression experiment

면역세포 내 함유되어 있는 총 RNA는 easy-BLUE 시약을 사용하여 추출하였다. 역 전사효소 MMLV를 사용하여 cDNA를 합성하였고 표 1의 primer 염기서열을 사용하여 PCR를 진행하였다. iNOS, IL-6, IL-12, GAPDH는 25cycle의 PCR을 수행하였고, 어닐링(annealing) 온도는 55℃로 진행하였다. COX-2는 32cycle의 PCR을 수행하였고 어닐링 온도는 57℃로 진행하였다.Total RNA contained in immune cells was extracted using easy-BLUE reagent. cDNA was synthesized using reverse transcriptase MMLV, and PCR was performed using the primer sequences in Table 1. iNOS, IL-6, IL-12, and GAPDH were subjected to 25 cycles of PCR, and the annealing temperature was 55°C. COX-2 performed 32 cycles of PCR and the annealing temperature was 57°C.

iNOSiNOS 199 bp199 bp sensesense 5`-CCT CCT CCA CCC TAC CAA GT-3` 5`-CCT CCT CCA CCC TAC CAA GT-3` anti-senseanti-sense 5`-CAC CCA AAG TGC TTC AGT CA-3` 5`-CAC CCA AAG TGC TTC AGT CA-3` COX-2COX-2 141 bp141 bp sensesense 5`-TGC TGT ACC AGC AGT GGC AA-3` 5`-TGC TGT ACC AGC AGT GGC AA-3` anti-senseanti-sense 5`-GCA GCC ATT TCC TTC TCT CC-3` 5`-GCA GCC ATT TCC TTC TCT CC-3` IL-6IL-6 141 bp141 bp sensesense 5`-AAG TGC ATC ATC GTT GTT TTC A-3` 5`-AAG TGC ATC ATC GTT GTT TTC A-3` anti-senseanti-sense 5`-GAG GAT ACC ACT CCC AAC AG-3` 5`-GAG GAT ACC ACT CCC AAC AG-3` IL-12IL-12 334 bp334 bp sensesense 5`-TCT AAC TTC AGC GCA GTG GA-3` 5`-TCT AAC TTC AGC GCA GTG GA-3` anti-senseanti-sense 5`-TGC GGT GGT GTA GTG AGT G-3` 5`-TGC GGT GGT GTA GTG AGT G-3` GAPDHGAPDH 123 bp123 bp sensesense 5`-AGG TCG GTG TGA ACG GAT TTG-3` 5`-AGG TCG GTG TGA ACG GAT TTG-3` anti-senseanti-sense 5`-TGT AGA CCA TGT AGT TGA GGT CA-3` 5`-TGT AGA CCA TGT AGT TGA GGT CA-3`

사. 형광염색 실험buy. Fluorescence staining experiment

p65 단백질과 TLR4 수용체의 활성을 확인하기 위하여 형광 염색을 통한 단백질 발현 실험을 진행하였다. 실험은 면역세포를 1×104 cell/mL 밀도로 젤라틴이 코팅된 커버글라스에 배양하였다. 굼벵이 추출물을 0 ~ 800㎍/mL 농도로 처리 1시간 후에 4%의 paraformaldehyde로 고정하였다. 고정된 세포에 0.1%의 Tritox-X100을 10분간 처리하고 저온의 PBST로 5분간 씻어주었다. 그 후 10%의 당나귀 혈청을 사용하여 블록킹(blocking)을 진행하고 p65와 TLR4 1차 항체를 4℃환경에서 12시간 동안 처리한다. 마지막으로 형광이 부착된 2차 항체를 실온에서 2시간 처리한다. 핵 염색을 위하여 DAPI를 300nM 농도로 10분간 처리한다. 형광 처리된 샘플을 형광현미경을 통하여 관찰하고 단백질 발현 정도를 확인한다.In order to confirm the activity of the p65 protein and the TLR4 receptor, protein expression experiments were performed through fluorescent staining. In the experiment, immune cells were cultured on a gelatin-coated cover glass at a density of 1×10 4 cell/mL. The slug extract was treated at a concentration of 0 ~ 800 μg/mL and fixed with 4% paraformaldehyde after 1 hour. The fixed cells were treated with 0.1% Tritox-X100 for 10 minutes and washed with cold PBST for 5 minutes. Thereafter, blocking is performed using 10% donkey serum, and p65 and TLR4 primary antibodies are treated at 4° C. for 12 hours. Finally, the fluorescent secondary antibody is treated at room temperature for 2 hours. For nuclear staining, DAPI was treated at a concentration of 300 nM for 10 minutes. Observe the fluorescence-treated sample through a fluorescence microscope and confirm the degree of protein expression.

[실험 결과] [Experiment result]

가. 굼벵이 열수 추출물의 세포독성 평가 및 세포 모양 관찰go. Cytotoxicity evaluation of slug hot water extract and cell shape observation

굼벵이 추출물의 독성 평가를 위하여 다양한 농도의 굼벵이 추출물을 생쥐 대식세포인 RAW 264.7 세포에 처리한 후 세포 생존율 분석 및 세포 모양 관찰을 실시하였다. 세포 모양의 변화를 관찰한 결과, 죽은 형태를 지닌 세포는 관찰할 수 없었다. 다만, 처리 전에는 원형모양을 하고 있던 대식세포들이 굼벵이 추출물 처리 후에는 길쭉한 모양으로 변한 것이 관찰되었다(도 1의 A). 이것은 고 농도의 굼벵이 추출물은 RAW 264.7 세포의 활성화를 유도한다는 것을 추측하게 한다. 도 1의 B를 보면 MTT 실험 결과 굼벵이 추출물은 세포 독성을 갖고 있지 않는 것으로 확인되었다. 도 1의 A 및 도 1의 B의 결과를 종합해보면 굼벵이 추출물은 세포 독성을 갖고 있지 않고 세포의 활성화를 유도한다는 것을 알 수 있다.To evaluate the toxicity of the slug extract, mouse macrophage RAW 264.7 cells were treated with the slug extract at various concentrations, and cell viability analysis and cell shape observation were performed. As a result of observing changes in cell shape, cells with a dead form could not be observed. However, it was observed that the macrophages, which had a circular shape before treatment, changed to an elongated shape after treatment with the slug extract (FIG. 1A). This leads us to speculate that high concentrations of slug extract induce activation of RAW 264.7 cells. Referring to B of FIG. 1, as a result of the MTT experiment, it was confirmed that the slug extract did not have cytotoxicity. When the results of FIG. 1A and FIG. 1B are taken together, it can be seen that the slug extract induces cell activation without having cytotoxicity.

나. NO와 PGE2 생성 평가 및 iNOS, COX-2 발현 평가me. Evaluation of NO and PGE2 production and evaluation of iNOS and COX-2 expression

굼벵이 추출물이 세포의 모양변화를 유도함에 따라 면역기능에 변화를 일으키는지 확인하였다. 먼저 주요 면역 매개 물질인 NO의 합성효소인 iNOS와 PGE2의 합성효소인 COX-2의 발현 변화를 비교한 결과 도 2의 A와 B를 보면 굼벵이 추출물의 처리가 iNOS의 mRNA와 단백질의 발현을 농도 의존적으로 뚜렷하게 증가시킴을 확인할 수 있었다. 도 2의 C와 D에서는 COX-2의 발현이 증가되었음을 확인하였다. 강한 면역 반응 물질인 LPS와의 발현 비교를 했을 때 굼벵이 추출물은 매우 강한 iNOS와 COX-2의 발현을 유도함을 알 수 있었다. 실질적으로 NO와 PGE2의 생성에도 영향을 주었는지 확인하였다. 도 2의 E와 F를 보면 높은 농도의 굼벵이 추출물은 NO와 PGE2의 생성을 매우 강하게 증가시켰음을 알 수 있었다. 하지만, 저농도의(100 ㎍/mL) 굼벵이 추출물은 NO와 PGE2의 생성에 영향을 주지 않았다. 도 2의 결과를 종합하면 고농도의 굼벵이 추출물은 iNOS와 COX-2의 발현을 증가시킴으로서 면역 매개 물질인 NO와 PGE2의 생성 증가를 유도하는 것을 알 수 있다. It was confirmed whether the slug extract induces a change in the immune function by inducing a change in cell shape. First, as a result of comparing the expression changes of COX-2, a synthetase of iNOS and PGE 2 , a synthase of NO, which is a major immune mediator, the results of FIG. It was confirmed that the concentration-dependent increase was evident. In C and D of FIG. 2 , it was confirmed that the expression of COX-2 was increased. When comparing the expression with LPS, a strong immune response substance, it was found that the slug extract induced very strong expression of iNOS and COX-2. It was also confirmed whether it substantially affected the production of NO and PGE 2 . Looking at E and F of FIG. 2 , it was found that the slug extract at a high concentration very strongly increased the production of NO and PGE 2 . However, a low concentration (100 μg/mL) of slug extract did not affect NO and PGE2 production. Summarizing the results of FIG. 2 , it can be seen that the high-concentration slug extract induces an increase in the production of NO and PGE 2 , which are immune mediators, by increasing the expression of iNOS and COX-2.

다. IL-6와 IL-12의 발현 및 생성 평가 all. Evaluation of expression and production of IL-6 and IL-12

굼벵이 추출물이 주요 면역 매개 물질의 발현을 유도함에 따라 다른 면역 유도 인자의 변화를 확인하기 위하여 IL-6와 IL-12의 발현 변화를 확인하였다. 도 3의 A와 B를 보면 고농도의(800㎍/mL) 굼벵이 추출물 처리는 생쥐 대식세포인 RAW 264.7 세포주에서 IL-6와 IL-12의 mRNA 발현을 매우 강하게 유도하였음을 확인할 수 있다. 이러한 결과는 LPS에 의해 자극된 대식세포의 mRNA 발현과 비견될 만큼의 강한 활성도였다. 실질적으로 IL-6와 IL-12의 생성을 비교한 결과를(도 3의 C와 D) 보면 고농도의 굼벵이 추출물은 매우 강한 염증인자 생성을 유도하는 것으로 확인되었다. 하지만 저농도의(100㎍/mL) 굼벵이 추출물은 IL-6와 IL-12의 발현에 영향을 줄 수 없는 것으로 확인되었다. 실험결과를 종합하면 저농도의 굼벵이 추출물은 면역 반응에 영향을 주지 않지만, 고농도의 굼벵이 추출물은 IL-6와 IL-12의 mRNA 발현을 유도함으로서 IL-6와 IL-12의 생성을 증가시켰고 이는 대식세포의 면역 활성을 유도하는 것으로 확인되었다. As the slug extract induced the expression of major immune mediators, changes in the expression of IL-6 and IL-12 were confirmed to confirm changes in other immune-inducing factors. 3A and B, it can be seen that treatment with a high concentration (800 μg/mL) of slug extract very strongly induced the mRNA expression of IL-6 and IL-12 in the mouse macrophage RAW 264.7 cell line. These results were strong enough to be comparable to the mRNA expression of macrophages stimulated by LPS. Substantially comparing the production of IL-6 and IL-12 (FIG. 3 C and D), it was confirmed that a high concentration of slug extract induces very strong inflammatory factor production. However, it was confirmed that a low concentration (100 μg/mL) of slug extract could not affect the expression of IL-6 and IL-12. Summarizing the experimental results, low concentration of slug extract did not affect the immune response, but high concentration of slug extract increased the production of IL-6 and IL-12 by inducing mRNA expression of IL-6 and IL-12. It has been confirmed to induce immune activity of phagocytes.

라. NF-κB 활성 변화와 그에 따른 면역 매개체 발현 변화 확인la. Confirmation of changes in NF-κB activity and corresponding changes in immune mediator expression

NF-κB는 면역 자극과 염증 유도 인자를 조절하는 핵심 전사 인자로서 대부분의 면역 매개 물질의 발현을 조절한다. 따라서 굼벵이 추출물의 면역 매개 물질 생성 촉진과 NF-κB의 활성 변화에 대한 실험을 진행하였다. NF-κB의 부속 단백질인 p65를 빨간색의 형광으로 염색하고 핵을 파란색으로 염색하여 관찰한 결과 세포질에 있던 p65가 핵안으로 이동하는 것이 관찰되었다(도 4의 A). 핵단백질을 추출하여 NF-κB 발현을 조사한 결과 역시 핵 안에 있는 p65와 p50 단백질의 발현이 증가된 것을 확인할 수 있다(도 4의 B). 따라서 NF-κB의 활성이 iNOS, COX-2, IL-6, IL-12의 발현에 영향을 줄 것이라고 생각되어 NF-κB억제제를 처리하여 발현을 비교해보았다(도 4의 C). 실험 결과 NF-κB 억제제는 iNOS, COX-2, IL-6, IL-12의 발현을 억제하였고 이는 굼벵이 추출물이 NF-κB의 활성을 유도함으로서 면역 매개 물질의 생성이 증가되었음을 의미한다. NF-κB is a key transcription factor that regulates immune stimulation and inflammation-inducing factors, and regulates the expression of most immune mediators. Therefore, an experiment was conducted to promote the production of immune mediators and change the activity of NF-κB in the slug extract. When p65, an accessory protein of NF-κB, was stained with red fluorescence and the nucleus was stained with blue, it was observed that p65 in the cytoplasm moved into the nucleus (FIG. 4A). As a result of examining NF-κB expression by extracting nuclear proteins, it was also confirmed that the expression of p65 and p50 proteins in the nucleus was increased (FIG. 4B). Therefore, it was thought that the activity of NF-κB would affect the expression of iNOS, COX-2, IL-6, and IL-12, and the expression was compared by treatment with an NF-κB inhibitor (FIG. 4C). As a result, the NF-κB inhibitor suppressed the expression of iNOS, COX-2, IL-6, and IL-12, which means that the slug extract induces NF-κB activity and increases the production of immune mediators.

마. 굼벵이 추출물의 면역기능 강화 기전 규명mind. Identification of the immune function enhancement mechanism of slug extract

대부분의 면역 반응은 TLR4 수용체 자극으로부터 시작되며, TLR4 수용체는 하위의 MyD88, IRAK4 단백질 활성 경로를 통하여 NF-κB의 활성을 유도한다고 알려져 있다. 따라서 굼벵이 추출물의 면역기능 강화 효능에 대한 기전을 규명하기 위해 TLR4의 형광 염색을 통한 발현(도 5의 A)과 MyD88, IRAK4 단백질의 발현(도 5의 B)을 확인하였다. 결과를 보면 굼벵이 추출물에 의해 녹색 형광으로 염색된 TLR4의 발현이 증가되는 것을 확인할 수 있으며 이는 LPS 자극과 비슷한 정도의 발현을 보이는 것으로 관찰되었다. MyD88과 IRAK4 단백질의 발현 역시 강하게 증가되었으며, 이 역시 LPS자극에 의한 발현 정도와 비슷하였다. 결론적으로 굼벵이 추출물은 TLR4 자극을 통한 MyD88, IRAK4 단백질의 활성으로 NF-κB의 전좌(핵안으로의 이동)를 유도함으로서 면역 기능이 강화되는 효과를 갖는 것으로 확인되었다. It is known that most immune responses start with stimulation of TLR4 receptors, and TLR4 receptors induce NF-κB activity through the lower MyD88 and IRAK4 protein activation pathways. Therefore, in order to identify the mechanism of the immune function enhancement effect of the slug extract, the expression of TLR4 through fluorescent staining (A in FIG. 5) and the expression of MyD88 and IRAK4 proteins (FIG. 5 B) were confirmed. As a result, it can be confirmed that the expression of TLR4 stained with green fluorescence is increased by the slug extract, which was observed to show a similar degree of expression to LPS stimulation. The expression of MyD88 and IRAK4 protein was also strongly increased, and this was also similar to the level of expression by LPS stimulation. In conclusion, it was confirmed that the slug extract has an effect of enhancing immune function by inducing translocation (translocation into the nucleus) of NF-κB by activating MyD88 and IRAK4 proteins through TLR4 stimulation.

Claims (5)

흰점박이꽃무지 유충 추출물을 유효성분으로 포함하는 면역기능 강화용 조성물.
A composition for strengthening immune function comprising an extract from the larvae of white-spotted radishes as an active ingredient.
제1항에 있어서,
상기 흰점박이꽃무지 유충 추출물은 열수 추출물인 것을 특징으로 하는 면역기능 강화용 조성물.
According to claim 1,
The white-spotted flower radish larvae extract is a composition for strengthening immune function, characterized in that the hot water extract.
제2항에 있어서,
상기 열수 추출물은 흰점박이꽃무지 유충을 건조 후 분쇄한 것을 증류수를 이용하여 추출한 후, 동결 건조하여 수득한 것을 특징으로 하는 면역기능 강화용 조성물.
According to claim 2,
The hot-water extract is a composition for enhancing immune function, characterized in that obtained by drying and pulverizing the larvae of the white-spotted flower radish, extracting them using distilled water, and then freeze-drying them.
제1항 내지 제3항 중 어느 한 항에 있어서,
상기 흰점박이꽃무지 유충 추출물은, 대식세포의 활성을 촉진하고 NO 생성을 촉진하는 동시에, PGE2, IL-6, IL-12의 생성을 촉진하는 효과를 갖는 것을 특징으로 하는 면역기능 강화용 조성물.
According to any one of claims 1 to 3,
The composition for enhancing immune function, characterized in that the extract of the white-spotted radish larvae promotes macrophage activity and NO production, and at the same time promotes the production of PGE2, IL-6, and IL-12.
(a) 흰점박이꽃무지 유충을 건조하는 단계;
(b) 상기 건조된 흰점박이꽃무지 유충을 분쇄하는 단계;
(c) 상기 분쇄된 흰점박이꽃무지 유충을 증류수에 침지하는 단계;
(d) 상기 용액을 진공 필터를 이용하여 용매를 제거하는 단계;및
(e) 상기 (d) 용액을 동결 건조하여 흰점박이꽃무지 유충 추출물을 수득하는 단계
를 포함하는 면역기능 강화용 조성물을 제조하는 방법.
(a) drying the white-spotted flower larvae;
(b) grinding the dried white-spotted flower larvae;
(c) immersing the pulverized white-spotted flower larvae in distilled water;
(d) removing the solvent from the solution using a vacuum filter; and
(e) freeze-drying the solution (d) to obtain an extract of the white-spotted flower radish larvae
Method for producing a composition for enhancing immune function comprising a.
KR1020210188966A 2021-12-27 2021-12-27 Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition KR20230099528A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1020210188966A KR20230099528A (en) 2021-12-27 2021-12-27 Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1020210188966A KR20230099528A (en) 2021-12-27 2021-12-27 Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition

Publications (1)

Publication Number Publication Date
KR20230099528A true KR20230099528A (en) 2023-07-04

Family

ID=87156215

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020210188966A KR20230099528A (en) 2021-12-27 2021-12-27 Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition

Country Status (1)

Country Link
KR (1) KR20230099528A (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100377252B1 (en) 2000-08-04 2003-03-26 김도진 Health food for anticancer

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100377252B1 (en) 2000-08-04 2003-03-26 김도진 Health food for anticancer

Similar Documents

Publication Publication Date Title
Zhang et al. Toxicology and immunology of Ganoderma lucidum polysaccharides in Kunming mice and Wistar rats
Kim et al. Activation of macrophages by polysaccharide isolated from Paecilomyces cicadae through toll-like receptor 4
Aminin et al. Immunomodulatory properties of frondoside A, a major triterpene glycoside from the North Atlantic commercially harvested sea cucumber Cucumaria frondosa
Adeyemi et al. Ethanolic leaf extract of Psidium guajava: Phytochemical and trypanocidal activity in rats infected with Trypanosoma brucei brucei
Mehdi et al. Phytochemical screening and antiamebic studies of Tamarindus indica of leaves extract
CN103269706A (en) Anti-cancer extract and compounds
CN100348218C (en) Composition comprising the extract of cistanche deserticola Y.C. ma showing enhancing activity of the neurite outgrowth and neurotrophic effects
Sa'adah et al. Bioprospecting of parijoto fruit extract (Medinilla speciosa) as antioxidant and immunostimulant: Phagocytosis activity of macrophage cells
KR20230099528A (en) Composition for inhancing immune function containing extract of Protaetia brevitarsis seulensis larvae and Method of producing the composition
Sogan et al. Myco-chemicals and teratogenic activity of wild mushroom Trichaleurina celebica from Mt. Palali, Quezon, Nueva Vizcaya, Luzon Island, Philippines
Randriamampianina et al. Marked toxicity of Albizia bernieri extracts on embryo–larval development in the medaka fish (Oryzias latipes)
RU2674033C1 (en) Method for obtaining a substance from the gonad mussels of mytilus galloprovincialis, which has antitumor activity
CN114480249B (en) Application of Pinctada martensii Bei Nianye in extracting exosomes, exosomes and extraction method and application thereof
EL-Tantawi et al. Evaluation of the side effects of different doses of spirulina on various organs in rats: Biochemical, histological and histochemical assessment
Li et al. Effect of procyanidins from Pinus koraiensis bark on growth inhibition and expression of PCNA and TNF-[alpha][alpha] in mice with U14 cervical cancer
Franchini et al. Feline pancreatic islet-like clusters and insulin producing cells express functional Toll-like receptors (TLRs)
CN115969889A (en) Application of cordyceps militaris sporocarp extract in preparing medicine for improving blue light injury resistance effect
CN105213523B (en) A kind of purposes of method and the extract that extracting effective ingredient from the coptis
KR101545495B1 (en) Pharmaceutical Composition and Functional Food for Preventing or Treating Neurodegenerative Disease by Saururus Chinesis Extracts and Quercetin as Effective Component, and Extracting Method of Saururus Chinesis Extracts
Syamsul et al. The Chemical Composition of Trigona Honey in Bone, South Sulawesi
Nori Mater et al. Effects of Avena sativa and Glycyrrhiza glabra leaves extracts on immune responses in serum cytokine and liver enzyme levels in NIH mice
RU2215532C2 (en) Method for complex processing sea cucumber viscera and preparing biologically active food supplements and biologically active food supplements "tingol-2" and "erogol"
CN110141566B (en) Application of SGLT2inhibitor in regulation and control of inflammation
Salih et al. The Effect Study Of Adding Extracts Of Some Medicinal Plants In The Bloody, Serological And Histological Changes Of Eimeria Necatrix And Compared With Amprolium In Broiler Chickens Ross 308
CN106177035B (en) Preparation method and application of effective rosa chinensis flower extract with blood sugar reducing and anticancer functions

Legal Events

Date Code Title Description
E902 Notification of reason for refusal